Ageing and inflammation
Burnet is working on ways to slow the detrimental biological process of inflammageing, the build-up of low-grade inflammation in the body, increasing the risk of age-related conditions. Our researchers discovered that the release of a certain cytokine transforms B cells into overactive aged B cells.
Our models could pave the way for therapeutics that slow or prevent inflammageing’s impact.
Inflammageing and models of chronic immune system decline
This flyer contains information about:
- the process of inflammageing and its impact on immune response
- our technology and models to screen therapeutics
- our track record in T and B cells and models of immunodeficiency.
